EN-US Sat, 25 May 2013 12:15:34 -0400 247402 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ieqFisFo274/premarket-most-active-for-may-21-2013-jaso-msft-sdbt-amat-acrx-csiq-cm247402 News Headlines Pre-market Most Active The NASDAQ 100 Pre-Market Indicator is up 2.06 to 3,023.03. The total Pre-Market volume is currently 15,484,775 shares traded. The following are the most active stocks for the pre-market<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/ieqFisFo274" height="1" width="1"/> Tue, 21 May 2013 16:39:53 Z 2013-05-21T13:04:48Z NASDAQ.com News ACRX AMAT CSIQ JASO MSFT SDBT http://www.nasdaq.com/article/premarket-most-active-for-may-21-2013-jaso-msft-sdbt-amat-acrx-csiq-cm247402 226423 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PJDlRdEtSS0/afterhours-earnings-report-for-march-12-2013-kw-dole-acad-gca-gnmk-avid-wsr-ktos-gern-acrx-fold-gcap-cm226423 News Headlines Earnings The following companies are expected to report earnings after hours on 03/12/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Kennedy-Wilson Holdings Inc. (<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/PJDlRdEtSS0" height="1" width="1"/> Tue, 12 Mar 2013 22:00:05 Z 2013-03-12T20:18:43Z NASDAQ.com News ACAD ACRX AVID DOLE FOLD GCA GCAP GERN GNMK KTOS KW WSR http://www.nasdaq.com/article/afterhours-earnings-report-for-march-12-2013-kw-dole-acad-gca-gnmk-avid-wsr-ktos-gern-acrx-fold-gcap-cm226423 208908 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9v74Lwgsu9Q/fda-approval-for-santarus-uceris-analyst-blog-cm208908 Investing Business Stocks Santarus Inc. ( SNTS ) recently announced that the US Food and Drug Administration (FDA) has granted approval to Uceris (budesonide) for the induction of remission in patients suffering<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/9v74Lwgsu9Q" height="1" width="1"/> Sat, 19 Jan 2013 00:50:01 Z 2013-01-18T22:20:54Z Zacks Equity Research ACRX SNTS http://www.nasdaq.com/article/fda-approval-for-santarus-uceris-analyst-blog-cm208908 208681 http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OIuPvFnVLDo/synergycallisto-merger-approved-analyst-blog-cm208681 Investing Business Stocks Synergy Pharmaceuticals Inc. 's ( SGYP ) stockholders recently approved Synergy Pharma's merger with Callisto Pharmaceuticals Inc. The deal was initially announced in Jul 2012 and later<img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/OIuPvFnVLDo" height="1" width="1"/> Fri, 18 Jan 2013 02:40:01 Z 2013-01-17T23:17:30Z Zacks Equity Research ACRX ANAC SGYP http://www.nasdaq.com/article/synergycallisto-merger-approved-analyst-blog-cm208681